Results 201 to 210 of about 127,720 (302)

Clinical Outcomes and New Treatments in Pediatric Brain Tumors. [PDF]

Curr Oncol
Erker C, Perreault S.
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

The High Cost of Misdiagnosis: The Challenges of Differentiating Grade-4 Astrocytoma from Glioblastoma in Resource-Constrained Countries. [PDF]

Pak J Med Sci
Saeed H, Qadri HM.
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition. [PDF]

Brain Pathol
Picca A, Barresi V, Trinquet A, Bertero L, Nichelli L, Chotard G, Bernier M, Gareau T, Kacimi SEO, Bhalshankar J, Filser M, Masliah-Planchon J, Iollo M, Malaize H, Mathon B, Bauchet L, Khouri K, Barka B, Madry H, Rossi S, Miele E, Ricciardi GK, Carpentier C, Coin I, Sanson M, Touat M, Dehais C, Pellerino A, Rudà R, Cassoni P, Rigau V, Uro-Coste E, Mokhtari K, Idbaih A, Benusiglio PR, Bielle F.   +35 more
europepmc   +1 more source

Orbital glioma.

Indian journal of ophthalmology, 1984
Mohan Reddy C, Hayath M, Dinakar I, Prabhakar V   +3 more
openaire   +2 more sources

Glycosylated dendrimer nanoamplifiers hijack DNA damage‐immune crosstalk for enhanced dual‐track therapy of orthotopic glioblastoma

BMEMat, EarlyView.
A glycosylated dendrimer nanoamplifier hijacks DNA damage‐immune crosstalk for enhanced radio‐immunotherapy of glioblastoma. The responsive release of demethylcantharidin simultaneously blocks repair‐mediated resistance by inhibiting DNA repair and overcomes adaptive immune resistance.
Cong Song, Binghan Liu, Junjie Liu, Ce Li, Wenqing Man, Xurui Sun, Chang Yuan, Yanjun Wang, Hong Pan, Shuanglian Wang, Zhiming Zheng   +10 more
wiley   +1 more source

Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab. [PDF]

J Neurooncol
Loxterkamp E, Luo A, Sanvito F, Le CT, Raymond C, Yang C, Prins TJ, Fisher A, Salamon N, Liau LM, Chong RA, Nghiemphu PL, Nathanson DA, Cloughesy TF, Lai A, Ellingson BM.   +15 more
europepmc   +1 more source

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source

Prostate-specific membrane antigen in malignant brain tumors: vascular heterogeneity, imaging promise, and therapeutic challenges. [PDF]

Front Oncol
Pokharel B, Feng M, Yang Y, Qi Z, Kazmi SS, Cao Y, Li L, Gao Y.   +7 more
europepmc   +1 more source